Date | Programmes | Podcast Title | |
---|---|---|---|
21-Nov-24 |
Morning Brief (7:30 AM) |
Changing Of The Guard At G20 Summit?
Chong Ja Ian, Associate Professor of Political Science, National University of Singapore (NUS) |
|
19-Nov-24 |
Top 5 At 5 (5:09 PM) |
Top 5 at 5: Bipartisan Pushback to Amend Act 346
Dr Farhan Rusli, Special Officer to the Minister of Health & Fellow, Institute for Research & Development of Policy |
|
02-Aug-24 |
Top 5 At 5 (5:00 PM) |
Top 5 At 5: Is a Global Wealth Tax a Fool's Errand?
Dr Geoffrey Williams, Economist |
|
13-Sep-23 |
Morning Brief (9:15 AM) |
India's Nifty 50 Scales New Highs
Pramod Amthe , Head Of Institutional Equity Research, InCred Capital |
|
11-Sep-23 |
Morning Brief (7:30 AM) |
India Brings G20 Summit Leaders Together
Bunn Nagara, Director and Senior Fellow, BRI Caucus for Asia-Pacific and Honorary Fellow, Perak Academy |
|
08-Sep-23 |
What's The Focus (9:30 AM) |
WTF: G20 Summit, With Love From Bharat?
|
|
18-Nov-22 |
What's The Focus (9:30 AM) |
WtF: High Stakes Politics - G20 & GE15
|
|
17-Nov-22 |
Morning Brief (7:30 AM) |
Curtain Closes On G20 Summit In Bali
Bunn Nagara, Honorary Research Fellow, Perak Academy |
|
20-Sep-22 |
Morning Brief (7:30 AM) |
Jokowi's Last Stand?
Resty Woro Yuniar, Correspondent, South China Morning Post |
|
15-Apr-20 |
Morning Brief (8:45 AM) |
Oil Markets: Can More Be Done to Support Prices?
Roger Diwan, Vice President Financial Services, IHS Markit |
|
03-Jul-19 |
Market Watch (7:05 AM) |
The Fear of Missing Out
Dodge Dorland, Chief Investment Officer, Landor Wealth Management |
|
01-Jul-19 |
Market Watch (7:05 AM) |
US-China Trade War: Avoiding a Full Escalation
Freddy Lim, Chief Investment Officer, Stashaway |
|
28-Jun-19 |
Morning Brief (7:30 AM) |
G20: All Eyes On Trump and Xi Jinping
Jahangir Aziz, Chief Emerging Market Economist , J.P. Morgan |
|
28-Jun-19 |
Market Watch (7:00 AM) |
The Elusive Trade Deal Scenario
Carlos Casanova, Chief Asia Economist, Coface |
|
27-Jun-19 |
Market Watch (7:00 AM) |
Short Term Relief Rally Post G20?
Vishnu Varathan, Head of Economics & Strategy, Mizuho Bank |
|
26-Jun-19 |
Market Watch (7:05 AM) |
Slack, Uber, Lyft - Time to Buy?
Dodge Dorland, Chief Investment Officer, Landor Wealth Management |
The 6AM Stretch
Thought-provoking discussions on ideas, people and events shaping our lives.
World Market Watch
Tony Nash of Complete Intelligence tells us where international markets are heading.
Morning Brief
We recap global and local headlines from today's papers and portals.
Morning Brief
Heron Lim, Economist at Moody’s Analytics discusses the impact of Trump's tariffs on China's economy.
Morning Brief
Prof. Azmi Hassan, Political Analyst and Senior Fellow at the Nusantara Academy weighs in on the three cornered fight in the Ayer Kuning By-election
The Breakfast Grille
Dr Mohd Afzanizam of Bank Muamalat & Dr Ong Kian Ming of Taylor’s University discusses the impact of Trump’s tariffs on Malaysia.
Morning Brief
Dr Renato Lima de Oliveira, Institute of Democracy and Economic Affairs (IDEAS) discusses the depletion of natural gas reserves in Malaysia.
Opening Bell
(REPEAT) Tony Nash of Complete Intelligence tells us where international markets are heading.
Opening Bell
Christopher Wong, FX Strategist at OCBC speaks about the impact of Trump’s tariffs on Asian currencies.
Ringgit & Sense
Jennifer Chua, licensed Financial Advisor at UOB Kay Hian talks about the ins and outs of planning for your parents' aged care.
Open For Business
How Nexacore Aims to Solve the ‘Last Mile’ Problem in Device Insurance
Tech Talk
Enterprise Explores
The Breakfast Grille Repeat
Dr Mohd Afzanizam of Bank Muamalat & Dr Ong Kian Ming of Taylor’s University discusses the impact of Trump’s tariffs on Malaysia.
Discovery Hour
An eclectic selection of BBC shows, curated with variety in mind.
Beyond the Ballot Box
In this conversation with Jomo Kwame Sundaram, we delve into the next stage of Malaysia's development, examining economic policy, structural challenges, and pathways for equitable growth.
Health & Living
How does the Ministry of Health decide what therapies are available in the public health system? And as more innovative and expensive therapies are developed, how do we balance cost with public need?
Top 5 at 5
Talkback Thursday
BBC World Service